An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II
Clinical trial NCT03708965 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03708965
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2026-12-31
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.